omniture
logo
Search
I PEACE INC.
Media Room

Latest News

rss

Vita Therapeutics and I Peace announced a development program to generate iPS-derived differentiated cells for transplant therapy with an initial focus on FSHD (Facioscapulohumeral Muscular Dystrophy) using universal iPS cells

PALO ALTO, Calif., July 10, 2025 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://ipeac...

2025-07-10 18:00 2780

I Peace Launches Personalized iPS Cell Services and Longevity Treatment in the U.S.

– Age-Reversed Stem Cell Technology Now Available to the Public – PALO ALTO, Calif., April 5, 2025 ...

2025-04-05 20:00 2860

I Peace establishes and offers low immunoreaction risk GMP iPS Cells

Three lines of GMP iPS Cells derived from type O female blood are now offered  as off-the-shelf prod...

2025-02-05 22:00 2439

I Peace manufactures 100 lines of GMP iPS Cells cumulatively

Proof of customer recognition of its quality and mass manufacturing capability PALO ALTO, Calif., D...

2024-12-31 04:24 1814

I Peace announces new iPSC lines to reduce immune rejection risk for U.S. population

More than 100 million people in the US have this HLA-A haplotype PALO ALTO, Calif., Oct. 29, 2024 /...

2024-10-30 02:55 1444

Stem Cell Therapy developers I Peace and iCamuno Biotherapeutics Start Natural Killer Cell Trial for Ovarian Cancer

PALO ALTO, Calif., Aug. 22, 2024 /PRNewswire/ -- I Peace, a pioneering CDMO in induced pluripotent ...

2024-08-22 21:00 1890

KOSÉ, I Peace, and Reju Enter Strategic Partnership to Develop Personalized Beauty Products Based on iPS Cells

Demonstration testing of "my own" beauty products PALO ALTO, Calif., July 9, 2024 /PRNewswire/ -- K...

2024-07-09 23:00 2737
KOSÉ, I Peace, and Reju Enter Strategic Partnership to Develop Personalized Beauty Products Based on iPS Cells

GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant

Starts undertaking quality evaluation and characterization of iPSCs in accordance with ISO standard...

2024-01-31 05:46 2452

GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant

Starts undertaking quality evaluation and characterization of iPSCs in accordance with ISO standard...

2023-12-06 22:30 1857

Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine

PALO ALTO, Calif., Nov. 1, 2023 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://www.ip...

2023-11-02 00:00 2407
Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine

I Peace, Inc. honored in BioSpectrum Asia Excellence Award 2022 with "Special Recognition in Cell Therapy"

PALO ALTO, Calif., Dec. 21, 2022 /PRNewswire/ -- I Peace, Inc. ( https://www.ipeace.com

2022-12-21 15:10 2486

I Peace partners with the California Institute for Regenerative Medicine [CIRM]

PALO ALTO, Calif., Nov. 1, 2022 /PRNewswire/ -- I Peace, Inc. ( https://www.ipeace.com

2022-11-02 00:00 2559

GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming

PALO ALTO, Calif., Sept. 20, 2022 /PRNewswire/ -- Koji Tanabe of I Peace, Inc. ( https://www.ipeace....

2022-09-21 05:39 1501
GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming

I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes.

PALO ALTO, Calif., May 11, 2022 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe ), aPalo Alto-based...

2022-05-12 00:00 2331

I Peace triples GMP cell manufacturing by expanding CDMO facility

PALO ALTO, Calif., March 14, 2022 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe), a Palo Alto-bas...

2022-03-15 03:22 1797

I Peace's Cell Manufacturing Facility "Peace Engine Kyoto" now registered as U.S. FDA Drug Establishment

PALO ALTO, Calif., Jan. 26, 2022 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe ), aPalo Alto-based...

2022-01-27 01:00 1840

Koji Tanabe, CEO of I Peace, Inc. honored by World Biz Magazine with "Top 100 Innovation CEO" Award

PALO ALTO, Calif., Sept. 21, 2021 /PRNewswire/ -- Koji Tanabe, Founder and CEO of I Peace, Inc. (ht...

2021-09-22 02:00 1846

Stem Cells for Everyone: I Peace expands its clinical-grade iPSC banking service leveraging mass manufacturing capability

PALO ALTO, Calif., Sept. 7, 2021 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe , https://ipeace.co...

2021-09-08 02:00 1774

I Peace's cell manufacturing facility "Peace Engine Kyoto" receives third-party certification as US cGMP compliant: the facility now meets the standard for both the US and Japanese markets

PALO ALTO, Calif., May 25, 2021 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe ), aPalo Alto-based ...

2021-05-26 03:00 1741

I Peace, Inc. and Avery Therapeutics announce collaboration to bring iPSC derived cell therapy for heart failure to the clinic

I Peace's GMP-grade iPSCs are key to manufacture Avery Therapeutics' MyCardia™, a proprietary tissu...

2020-12-17 08:41 2092
I Peace, Inc. and Avery Therapeutics announce collaboration to bring iPSC derived cell therapy for heart failure to the clinic
12